Download PDF
Thromb Haemost 1998; 80(03): 528-529
DOI: 10.1055/s-0037-1615247
Letters to the Editor
Schattauer GmbH

Inhibitory Effect of Argatroban on Thrombin-induced MAP Kinase Activation

A. Hijikata-Okunomiya
1   From Kobe University School of Medicine, Kobe, Japan
,
Y. Nakaya
1   Kobe Research Projects on Thrombosis and Haemostasis, Kobe, Japan
,
A. Takahashi
1   From Kobe University School of Medicine, Kobe, Japan
,
N. Inoue
1   From Kobe University School of Medicine, Kobe, Japan
,
T. Taniguchi
1   From Kobe University School of Medicine, Kobe, Japan
,
Y. Ishikawa
1   From Kobe University School of Medicine, Kobe, Japan
› Author Affiliations
Further Information

Publication History

Received 24 March 1998

Accepted after revision 20 May 1998

Publication Date:
08 December 2017 (online)

Also available at
    Permissions and Reprints

 

 

  • References

  • 1 Okamoto S, Hijikata A, Kikumoto R, Tonomura S, Hara H, Ninomiya K, Maruyama A, Sugano M, Tamao Y. Potent inhibition of thrombin by the newly synthesized arginine derivative No. 805. The importance of stereo-structure of its carboxamide portion. Biochem Biophys Res Commun 1981; 101: 440-6.
    CrossrefPubMedGoogle Scholar
  • 2 Hijikata-Okunomiya A, Okamoto S. A strategy for a rational approach to designing synthetic selective inhibitors. Semin Thromb Hemost 1992; 18: 135-49.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 3 Tanabe T, Mishima Y, Furukawa K, Sakaguchi S, Kamiya K, Shionoya S, Katsumura T, Kusaba A. Clinical results of MD805, antithrombin agent, on chronic arterial occlusion – multi-center cooperative study. J Clin Ther Med 1986; 2: 1645-55.
    PubMedGoogle Scholar
  • 4 Yonekawa Y, Handa H, Okamoto S, Kamijo Y, Oda Y, Ishikawa J, Tsuda H, Shimizu Y, Satoh M, Yamagami T, Yano I, Horikawa Y, Tsuda E. Treatment of cerebral infarction in the acute stage with synthetic antithrombin MD805: Clinical study among multiple institutions. Arch Jpn Chir 1986; 55: 711-26.
    PubMedGoogle Scholar
  • 5 Suzuki S, Sakamoto S, Adachi K, Mizutani K, Koide M, Ohga N, Miki T, Matsuo T. Effect of argatroban on thrombus formation during acute coronary occlusion after balloon angioplasty. Thromb Res 1995; 77: 369-73.
    CrossrefPubMedGoogle Scholar
  • 6 Molloy CJ, Pawlowski JE, Taylor DS, Turner CE, Weber H, Peluso M, Seiler SM. Thrombin receptor activation elicits rapid protein tyrosine phosphorylation and stimulation of the raf-1/MAP kinase pathway preceding delayed mitogenesis in cultured rat aortic smooth muscle cells. J Clin Invest 1996; 97: 1173-83.
    CrossrefPubMedGoogle Scholar
  • 7 McNamara CA, Sarembock IJ, Gimple LW, Fenton II JW, Coughlin SR, Owens GK. Thrombin stimulates proliferation of cultured rat aortic smooth muscle cells by a proteolytically activated receptor. J Clin Invest 1993; 91: 94-8.
    CrossrefPubMedGoogle Scholar
  • 8 Imanishi T, Arita M, Hamada M, Tomobuchi Y, Hano T, Nishio I. Effect of locally administration of argatroban using a hydrogel-coated balloon catheter on intimal thickening induced by balloon injury. Jpn Circ J 1998; 61: 256-62.
    PubMedGoogle Scholar